Table of Content




1. Research Methodology


2. Executive Summary


3. Strategic Recommendations


4. Liquid Biopsy Market: Product Outlook


5. Global Liquid Biopsy Market: Growth and Forecast (2017-2024)


6. Global Liquid Biopsy Market: Segment Analysis

6.1 Global Liquid Biopsy Market Size, By Cancer Type: Breakdown (%)
6.2 Global Lung Cancer Liquid Biopsy Market, By Value (2017-2024)
6.3 Global Breast Cancer Liquid Biopsy Market, By Value (2017-2024)
6.4 Global Colorectal Cancer Liquid Biopsy Market, By Value (2017-2024)
6.5 Global Prostate Cancer Liquid Biopsy Market, By Value (2017-2024)
6.6 Global Others Liquid Biopsy Market, By Value (2017-2024)
6.7 Market attractiveness of Global Liquid Biopsy Market- By Cancer Type
6.8 Global Liquid Biopsy Market Size, By Circulating Biomarker: Breakdown (%)
6.9 Global CTC Liquid Biopsy Market, By Value (2017-2024)
6.10 Global ct-DNA Liquid Biopsy Market, By Value (2017-2024)
6.11 Global Vesicle Liquid Biopsy Market, By Value (2017-2024)
6.12 Market attractiveness of Global Liquid Biopsy Market- By Circulating Biomarker
6.13 Global Liquid Biopsy Market Size, By Product Type: Breakdown (%)
6.14 Global Reagent Liquid Biopsy Market, By Value (2017-2024)
6.15 Global Instrument Liquid Biopsy Market, By Value (2017-2024)


7. Global Liquid Biopsy Market: Regional Analysis
7.1 Global Liquid Biopsy Market Size, By Region : Breakdown (%)
7.1.1 Global Liquid Biopsy Market Size, By Region, 2024 (%)

7.2 North America Liquid Biopsy Market: Growth and Forecast
7.2.1 By Value (2017-2024)
7.2.2 By Cancer Type, By Value (2017-2024)
7.2.3 By Circulating Biomarker, By Value (2017-2024)
7.2.4 By Product Type, By Value (2017-2024)
7.3 North America Liquid Biopsy Market: Country Analysis (U.S)
7.3.1 U.S Liquid Biopsy Market, By Value (2017-2024)
7.3.2 U.S Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.3.3 U.S Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.3.4 U.S Liquid Biopsy Market, By Product Type, By Value (2017-2024)

7.4 Europe Liquid Biopsy Market: Growth and Forecast
7.4.1 By Value (2017-2024)
7.4.2 By Cancer Type, By Value (2017-2024)
7.4.3 By Circulating Biomarker, By Value (2017-2024)
7.4.4 By Product Type, By Value (2017-2024)
7.5 Europe Liquid Biopsy Market: Country Analysis (Germany, France)
7.5.1 Germany Liquid Biopsy Market, By Value (2017-2024)
7.5.2 Germany Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.5.3 Germany Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.5.4 Germany Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.5.5 France Liquid Biopsy Market, By Value (2017-2024)
7.5.6 France Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.5.7 France Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.5.8 France Liquid Biopsy Market, By Product Type, By Value (2017-2024)

7.6 APAC Liquid Biopsy Market: Growth and Forecast
7.6.1 By Value (2017-2024)
7.6.2 By Cancer Type, By Value (2017-2024)
7.6.3 By Circulating Biomarker, By Value (2017-2024)
7.6.4 By Product Type, By Value (2017-2024)
7.7 APAC Liquid Biopsy Market: Country Analysis (Japan)
7.7.1 Japan Liquid Biopsy Market, By Value (2017-2024)
7.7.2 Japan Liquid Biopsy Market, By Cancer Type, By Value (2017-2024)
7.7.3 Japan Liquid Biopsy Market, By Circulating Biomarker, By Value (2017-2024)
7.7.4 Japan Liquid Biopsy Market, By Product Type, By Value (2017-2024)
7.8 ROW Liquid Biopsy Market: Growth and Forecast
7.8.1 By Value (2017-2024)
7.8.2 By Cancer Type, By Value (2017-2024)
7.8.3 By Circulating Biomarker, By Value (2017-2024)
7.8.4 By Product Type, By Value (2017-2024)


8. Global Liquid Biopsy Market: Competitive Landscape
8.1 Market share of Leading Global Companies
8.2 Global Liquid Biopsy Market : Investments and Partnerships
8.3 Global Liquid Biopsy Market: Product Analysis


9. Global Liquid Biopsy Market Dynamics
9.1 Global Liquid Biopsy Market Drivers
9.1.1 Rising incidence of cancer
9.1.2 Growing focus on immunotherapy to cure cancer
9.1.3 Growing government expenditure in cancer research
9.2 Global Liquid Biopsy Market Restraints
9.2.1 Technology is dependent upon the interest shown by third party payers
9.3 Global Liquid Biopsy Market Trend
9.3.1 Adoption of precision medicine for curing cancer
9.3.2 Early detection of cancer


10. Porter’s Five Forces Analysis


11. SWOT Analysis


12. Policy and Regulatory Landscape


13. Company Profiles
13.1 Guardant Health
13.2 Roche Diagnostics
13.3 Thermo Fisher Scientific
13.4 Qiagen